Table 2 (abstract A52). See text for description
From: Abstracts of the ICARE 2024 78th SIAARTI National Congress
| Â | Patient 1 | Patient 2 | Patient 3 |
|---|---|---|---|
Sex | Male | Male | Female |
Age (years) | 75 | 53 | 64 |
Weight (kg) / BMI (kg/m2) | 75 / 32 | 96 / 26,9 | 50 / 22,2 |
Diagnosis at admission | respiratory failure | respiratory failure | double-lung transplant |
APACHE II score | 26 | 24 | 26 |
SOFA score | 15 | 13 | 15 |
NYHA | Class II | Class I | Class III |
Medical history | type 2 diabetes mellitus on insulin therapy | active smoker | severe pulmonary hypertension |
previous enucleation of left kidney | Â | usual interstitial pneumonia (UIP) | |
radical cysto-prostatectomy, residual cutaneous ileal-cystostomy | Â | acute heart failure, mild mitral regurgitation, mild to moderate aortic stenosis | |
myasthenia gravis (no treatment) | Â | intermediate (50%) stenosis of the anterior descending artery | |
| Â | Â | paroxysmal atrial fibrillation on direct oral anticoagulants | |
| Â | Â | GERD from H. pylori | |
| Â | Â | iron-deficiency anaemia | |
| Â | Â | nodular formation in left breast | |
acute kidney injury stage (KIDGO criteria) | AKI G3 | AKI G3 | AKI G3 |
Type of RRT | CVVHDF | CVVHDF | CVVHDF |
Set | ST-150 | ST-150 | ST-150 |
Anti-coagulation | regional citrate anticoagulation (RCA) | none | none |
Blood flow (ml/min) | 120 | 200 | 200 |
PBP flow (ml/h) | 1000 (Regiocit) | 500 (Prismasol 2) | 400 (Prismasol 2) |
Dialysate flow (ml/h) | 1100 (Prism0cal B22) | 2500 (Prismasol 2) | 1500 (Prismasol 2) |
Reinfusion flow (ml/h) | 500 (Phoxilium) | 500 (Prismasol 2) | 400 (Prismasol 4) |
Pre-dilution (%) | 0 | 0 | 0 |
Calcium compensation (%) | 100 | 100 | 100 |
Treatment duration in hours per day | 24 | 24 | 24 |